1.Baruch, I, Hemsley, DR, Gray, JA. Differential performance of acute and chronic schizophrenics in a latent inhibition task. J Nerv Ment Dis. 1988;176(10):598–606.
2.Pfohl, B, Winokur, G. The evolution of symptoms in institutionalized hebephrenic/catatonic schizophrenics. Br J Psychiatry J Ment Sci. 1982;141:567–572.
3.Liddle, PF. The symptoms of chronic schizophrenia. A re-examination of the positive-negative dichotomy. Br J Psychiatry J Ment Sci. 1987;151:145–151.
4.Stein, K, Broome, MR. Neuroprogression in schizophrenia: pathways and underpinning clinical staging and therapeutic corollaries. Aust N Z J Psychiatry. 2015;49(2):183–184.
5.Davis, J, Moylan, S, Harvey, BH, Maes, M, Berk, M. Neuroprogression in schizophrenia: pathways underpinning clinical staging and therapeutic corollaries. Aust N Z J Psychiatry. 2014;48(6):512–529.
6.Lieberman, JA, Sheitman, BB, Kinon, BJ. Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity. Neuropsychopharmacology. 1997;17(4):205–229.
7.Fountoulakis, KN, Dragioti, E, Theofilidis, AT, et al.Staging of schizophrenia with the use of PANSS: an International Multi-Center Study. Int J Neuropsychopharmacol. 2019;22(11):681–697.
8.APA. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. Washington, DC: American Psychiatric Association; 2013.
9.APA. Diagnostic and Statistical Manual of Mental Disorders: Fourth Edition Text Revision DSM-IV-TR. Washington, DC: American Psychiatric Association; 2000.
10.Kay, SR. Positive-negative symptom assessment in schizophrenia: psychometric issues and scale comparison. Psychiatr Quarter. 1990;61(3):163–178.
11.Kay, SR, Fiszbein, A, Opler, LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261–276.
12.Kay, SR, Opler, LA, Lindenmayer, JP. Reliability and validity of the positive and negative syndrome scale for schizophrenics. Psychiatry Res. 1988;23(1):99–110.
13.Kay, SR, Sandyk, R. Experimental models of schizophrenia. Int J Neurosci. 1991;58(1–2):69–82.
14.Kay, SR, Sevy, S. Pyramidical model of schizophrenia. Schizophr Bull. 1990;16(3):537–545.
15.Millan, MJ, Andrieux, A, Bartzokis, G, et al.Altering the course of schizophrenia: progress and perspectives. Nat Rev Drug Discov. 2016;15(7):485–515.
16.Andreasen, NC, Olsen, S. Negative v positive schizophrenia. Definition and validation. Arch Gen Psychiatry. 1982;39(7):789–794.
17.Crow, TJ. The two-syndrome concept: origins and current status. Schizophr Bull. 1985;11(3):471–486.
18.Andreasen, NC, Paradiso, S, O'Leary, DS. "Cognitive dysmetria" as an integrative theory of schizophrenia: a dysfunction in cortical-subcortical-cerebellar circuitry? Schizophr Bull. 1998;24(2):203–218.
19.Hemsley, DR. The development of a cognitive model of schizophrenia: placing it in context. Neurosci Biobehav Rev. 2005;29(6):977–988.
20.de Lafuente, V, Romo, R. Dopamine neurons code subjective sensory experience and uncertainty of perceptual decisions. Proc Natl Acad Sci U S A. 2011;108(49):19767–19771.
21.de Lafuente, V, Romo, R. Dopaminergic activity coincides with stimulus detection by the frontal lobe. Neuroscience. 2012;218:181–184.
22.Beck, AT, Rector, NA. Cognitive approaches to schizophrenia: theory and therapy. Ann Rev Clin Psychol. 2005;1:577–606.
23.Howes, OD, Murray, RM. Schizophrenia: an integrated sociodevelopmental-cognitive model. Lancet. 2014;383(9929):1677–1687.
24.Davis, J, Eyre, H, Jacka, FN, et al.A review of vulnerability and risks for schizophrenia: beyond the two hit hypothesis. Neurosci Biobehav Rev. 2016;65:185–194.
25.Ciompi, L. The natural history of schizophrenia in the long term. Br J Psychiatry J Ment Sci. 1980;136(5):413–420.
26.Davidson, M, Harvey, PD, Haroutunian, V, et al.Symptom severity and cognitive impairment in elderly schizophrenic patients. Schizophr Res. 1993;9(2–3):97.
27.Miller, R. Schizophrenia as a progressive disorder – relations to Eeg, Ct, neuropathological and other evidence. Prog Neurobiol. 1989;33(1):17–44.
28.Goldberg, TE, Gold, JM, Greenberg, R, et al.Contrasts between patients with affective disorders and patients with schizophrenia on a neuropsychological test battery. Am J Psychiatry. 1993;150(9):1355–1362.
29.McKenna, PJ, Lund, CE, Mortimer, AM. Negative symptoms: relationship to other schizophrenic symptom classes. Br J Psychiatry. 1989;155(7):104–107.
30.Goldberg, TE, Ragland, JD, Torrey, EF, Gold, JM, Bigelow, LB, Weinberger, DR. Neuropsychological assessment of monozygotic twins discordant for schizophrenia. Arch Gen Psychiatry. 1990;47(11):1066–1072.
31.Goldberg, TE, Torrey, EF, Gold, JM, et al.Genetic risk of neuropsychological impairment in schizophrenia: a study of monozygotic twins discordant and concordant for the disorder. Schizophr Res. 1995;17(1):77–84.
32.Suddath, RL, Christison, GW, Torrey, EF, Casanova, MF, Weinberger, DR. Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia. N Engl J Med. 1990;322(12):789–794.
33.Kaprinis, GS, Fountoulakis, KN, Kaprinis, SG. Arguments against the cognitive dysmetria hypothesis of schizophrenia. Percept Mot Skills. 2002;94(3 Pt 1):975–984.
34.Goldberg, TE, Hyde, TM, Kleinman, JE, Weinberger, DR. Course of schizophrenia: neuropsychological evidence for a static encephalopathy. Schizophr Bull. 1993;19(4):797–804.
35.Hoff, AL, Riordan, H, O'Donnell, DW, Morris, L, DeLisi, LE. Neuropsychological functioning of first-episode schizophreniform patients. Am J Psychiatry. 1992;149(7):898–903.
36.Weinberger, DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry. 1987;44(7):660–669.
37.Picchioni, M, Harris, S, Reichenberg, A, Fahy, T, Murphy, D. A neuro-psychological model of violence propensity in schizophrenia. Eur Psychiatry. 2016;33:S573.
38.Lieberman, JA, Perkins, D, Belger, A, et al.The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches. Biol Psychiatry. 2001;50(11):884–897.
39.Mohler, H, Rudolph, U. Disinhibition, an emerging pharmacology of learning and memory. F1000Res. 2017;6
40.Goldberg, TE, Weinberger, DR, Berman, KF, Pliskin, NH, Podd, MH. Further evidence for dementia of the prefrontal type in schizophrenia? A controlled study of teaching the Wisconsin Card Sorting Test. Arch Gen Psychiatry. 1987;44(11):1008–1014.
41.Wunderink, L, Nieboer, RM, Wiersma, D, Sytema, S, Nienhuis, FJ. Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance treatment strategy: long-term follow-up of a 2-year randomized clinical trial. JAMA Psychiatry. 2013;70(9):913–920.
42.Andreasen, NC, Liu, D, Ziebell, S, Vora, A, Ho, BC. Relapse duration, treatment intensity, and brain tissue loss in schizophrenia: a prospective longitudinal MRI study. Am J Psychiatry. 2013;170(6):609–615.
43.Lorr, M, Mc, ND, Klett, CJ, Lasky, JJ. Evidence of ten psychotic syndromes. J Consult Psychol. 1962;26:185–189.
44.Kitamura, T, Okazaki, Y, Fujinawa, A, Yoshino, M, Kasahara, Y. Symptoms of psychoses. A factor-analytic study. Br J Psychiatry J Ment Sci. 1995;166(2):236–240.
45.Van Os, J, Gilvarry, C, Bale, R, et al.A comparison of the utility of dimensional and categorical representations of psychosis. UK700 Group. Psychol Med. 1999;29(3):595–606.
46.Peralta, V, Cuesta, MJ. Dimensional structure of psychotic symptoms: an item-level analysis of SAPS and SANS symptoms in psychotic disorders. Schizophr Res. 1999;38(1):13–26.
47.Fountoulakis, KN, Popovic, D, Mosheva, M, Siamouli, M, Moutou, K, Gonda, X. Mood symptoms in stabilized patients with schizophrenia: a bipolar type with predominant psychotic features? Psychiatr Danub. 2017;29(2):148–154.
48.van Os, J, Fahy, TA, Jones, P, et al.Psychopathological syndromes in the functional psychoses: associations with course and outcome. Psychol Med. 1996;26(1):161–176.
49.McGorry, PD, Bell, RC, Dudgeon, PL, Jackson, HJ. The dimensional structure of first episode psychosis: an exploratory factor analysis. Psychol Med. 1998;28(4):935–947.
50.Willem Van der Does, AJ, Dingemans, PM, Linszen, DH, Nugter, MA, Scholte, WF. Dimensions and subtypes of recent-onset schizophrenia. A longitudinal analysis. J Nerv Ment Dis . 1995;183(11):681–687.
51.Salokangas, RK. Structure of schizophrenic symptomatology and its changes over time: prospective factor-analytical study. Acta Psychiatr Scand. 1997;95(1):32–39.
52.Ran, MS, Weng, X, Chan, CL, et al.Different outcomes of never-treated and treated patients with schizophrenia: 14-year follow-up study in rural China. Br J Psychiatry J Ment Sci. 2015;207(6):495–500.